Medicare
Commentary
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Blog
Prop 23 – Do we really need a doctor in the house?
Back in the November 2018 election, California voters were forced to pretend to be health care executives when they were asked to decide whether to require dialysis clinics to give refunds to patients (or patients’ insurers) if profits were above 115 percent of the costs of patient care and healthcare improvements. ...
Drug Pricing
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Commentary
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Commentary
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Commentary
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
Commentary
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Commentary
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Commentary
Price Controls Are Disastrous For Rents And Will Be For Drugs
President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Commentary
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Import German drug prices to the United States? Nein, danke
President Trump recently issued a blitz of executive orders in an attempt to fulfill his promise to reduce drug prices. One of those orders would put in place a “cure” far worse than the disease. The order in question establishes foreign reference pricing, whereby the federal government ties its reimbursement rates for ...
Prop 23 – Do we really need a doctor in the house?
Back in the November 2018 election, California voters were forced to pretend to be health care executives when they were asked to decide whether to require dialysis clinics to give refunds to patients (or patients’ insurers) if profits were above 115 percent of the costs of patient care and healthcare improvements. ...
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
A new brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute found that reforms mandating drug rebates benefit patients rather than payers would lower overall health care costs and help patients with expensive out-of-pocket drug costs. Click here to download the brief “Ironically, ...
Massive coverage losses are greatly exaggerated
Roughly 6.2 million U.S. workers lost employer-sponsored insurance coverage between February and July. Factor in family members and dependents, and that number increases to 12 million people. Estimates like this underpin a narrative that large segments of the country are unable to get medical care in the midst of the ...
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
This week, President Donald Trump and Democratic presidential nominee Joe Biden will square off in Cleveland for the first of three debates. The two candidates will have no shortage of disagreements to air, but one subject in particular is sure to receive significant attention—health care. From the pandemic response to the ...
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
The death of Justice Ruth Bader Ginsburg has suddenly made the demise of ObamaCare a possibility. The Supreme Court is scheduled to hear a case challenging the law’s constitutionality, California v. Texas, on Nov. 10, just a week after the election. Justice Ginsburg was a sure vote to uphold ObamaCare. Her replacement may not be. What would a ...
How Trump can trounce Biden on healthcare
In the first presidential debate on Tuesday, healthcare is sure to be one of the chief topics of conversation, especially now that a newly constituted Supreme Court could strike down Obamacare, effective perhaps as early as next year. At the debate, Joe Biden will almost certainly go after President Trump ...
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Price Controls Are Disastrous For Rents And Will Be For Drugs
President Trump and senior advisor Jared Kushner claim that the most favored nation executive order signed by the President over the weekend is necessary for drug pricing because “the U.S. shouldn’t pay more than other European countries for the same treatments.” This policy will make things worse, not better. If the president ...
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
